Fig. 2From: A case of malignant hyperthermia that was difficult to be differentiated from oral antipsychotic polypharmacy-associated neuroleptic malignant syndromeComparison between CICR rate of this case and the reference values for malignant hyperthermia susceptibility diagnosis in Japan [14]. The data of this case are compatible with clearly high rate of CICR. Courtesy of Drs. Hirosato Kikuchi and Yasuko Ichihara (Saitama Medical University) for measuring CICR rate of this caseBack to article page